HMHeloisa Helena de Sousa Marques

Heloisa Helena de Sousa Marques

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Heloisa Helena de Sousa Marques has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Oral health-related quality of life of paediatric patients with AIDS

    by Débora B Massarente, Carina Domaneschi, Heloísa Hs Marques, Samantha B Andrade, Daniela Goursand, José Lf Antunes

    Background: Children with Acquired Immune Deficiency Syndrome (AIDS) exhibit impaired dental status, which can affect their quality of life. This study assessed the oral health-related quality of life of these patients and associated factors. Methods: The "Child Perceptions Questionnaire 11-14", rating overall and domain-specific (oral symptoms, functional limitations, emotional well being, and social well being) oral health-related quality of life (OHR-QoL) was completed by 88 children with AIDS assisted in the Child Institute, Sao Paulo, Brazil. Parents or guardians provided behavioural and socio-demographic information. The clinical status was provided by hospital records. OHR-QoL covariates were assessed by Poisson regression analysis. Results: The most affected OHR-QoL subscale concerned oral symptoms, whose rate was 23.9%. The direct answer for oral health and well being made up a rate of 47.7%. Brushing the teeth less than two times a day and viral load exceeding 10,000 HIV-RNA copies per millilitre of plasma were directly associated (p < 0.05) with a poorer oral health-related quality of life. Conclusions: Children with more severe AIDS manifestations complained of poorer status of oral symptoms, functional limitations, emotional and social well being related to their oral health. Recognizing the factors that are associated with poorer OHR-QoL in children with AIDS may contribute to the planning of dental services for this population.


  • Validity and reliability of a self-efficacy expectancy scale for adherence to antiretroviral therapy for parents and carers of children and adolescents with HIV/AIDS.

    by Luciana Scarlazzari Costa, Maria Do Rosário D. O. Latorre, Mariliza Henrique da Silva, Daniela Vinhas Bertolini, Daisy Maria Machado, Sidnei Rana Pimentel, HeloÍSa Helena de Sousa Marques

    To validate and evaluate the reproducibility of a self-efficacy (SE) scale for adherence to antiretroviral therapy in children and adolescents with HIV/AIDS, taking into account the perspective of parents/guardians.


  • Open Access

    Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS

    by Heloisa Helena de Sousa Marques, Bernard François Couttolenc, Maria Do Rosário Dias de Oliveira Latorre, Maria Zilda de Aquino, Maria Ignez Garcia Aveiro, Ana Maria Aratangy Pluciennik

    The objective of this study was to estimate and analyze the costs of treating children with HIV/AIDS at a university hospital in São Paulo, Brazil. The study collected and analyzed data from 291 medical records of children treated at the hospital as of March 2002. The costs of treatment were estimated for each category of patient (exposed and infected) and severity, based on the quantity of inputs and procedures used in treating each child, based on the cost accounting system used at the hospital. The total cost of treatment for children exposed to the HIV was R$ 956.41 and for those infected with HIV R$ 8,092.71 per year. The mean cost of ambulatory care was R$ 6,047.28 for children with severe conditions, R$ 3,714.45 for those with light/moderate conditions, and R$ 948.63 for the exposed. Hospitalized children had annual costs of R$ 19,353.34, R$ 18,823.16, and R$ 871.03, respectively. The medication was a major factor in the cost of treatment. Our estimates are comparable to the findings from other studies, but lower than corresponding findings from the international literature.


  • Open Access

    A revelação do diagnóstico na perspectiva dos adolescentes vivendo com HIV/AIDS e seus pais e cuidadores

    by Heloisa Helena de Sousa Marques, Neide Gravato da Silva, Pilar Lecussan Gutierrez, Regina Lacerda, José Ricardo Carvalho Mesquita Ayres, Marinella DellaNegra, Ivan França Jr., Eliane Galano, Vera Paiva, Aluisio Augusto Cotrim Segurado, et al.

    O objetivo deste estudo foi identificar aspectos da revelação do diagnóstico da infecção pelo HIV a crianças e adolescentes relevantes para a melhoria do cuidado de sua saúde. Trata-se de estudo qualitativo envolvendo entrevistas em profundidade e grupo focal com adolescentes vivendo com HIV/AIDS e seus pais ou cuidadores, em serviços de referência nas cidades de São Paulo e Santos, Brasil. Os resultados apontam como principais razões para a revelação: má adesão ao tratamento, iminência de início da vida sexual, demanda da criança ou adolescente e abordagem inadequada de profissional. A revelação mostrou-se momento crítico, com repercussões sobre projetos e horizontes de vida dos adolescentes. As mais problemáticas foram narradas por adolescentes infectados por via sexual e por uso de drogas. Apesar do impacto negativo inicial, a revelação repercutiu positivamente sobre os cuidados de saúde, com melhoria do diálogo com cuidadores e serviços. Os adolescentes enfatizaram ainda a necessidade de receber informações claras e honestas. Conclui-se pela necessidade de otimizar o processo de revelação, tratando-o como tarefa de longo prazo, negociada ativamente com a família e conduzida por equipes multidisciplinares.


  • Recomendação da Sociedade Brasileira de Pediatria para antibioticoterapia em crianças e adolescentes com pneumonia comunitária

    by Cristiana M. Nascimento-Carvalho, Heloísa H. Souza-Marques

    To standardize the use of antibiotics to treat community-acquired pneumonia in children and adolescents in Brazil. The following data sources were utilized: the Medline and LILACS (Literatura Latino-Americana e do Caribe em Ciências da Saúde) bibliographic databases; World Health Organization and Pan American Health Organization documents published between 1980 and 2002; Internet materials in Portuguese, Spanish, or English located using the search terms "pneumonia, child, adolescent, etiology, treatment"; and interviews with renowned experts in the field. Hospitalization is always required for children younger than 2 months of age. That age group should be treated with ampicillin and aminoglycosides or third-generation cephalosporins. Children older than 2 months must be hospitalized if there is severe pneumonia. Tachypnea should be used as the criterion to distinguish between acute respiratory infection and pneumonia. Pneumonia is considered to be very severe when there are seizures, sleepiness, stridor at rest, severe malnutrition, no ingestion of fluids, or signs of respiratory failure such as central cyanosis. Children who are 2 months of age or older may receive outpatient treatment with amoxicillin or penicillin G procaine. In the case of inpatient treatment, crystalline penicillin or ampicillin may be used for severe cases, and oxacillin and chloramphenicol or ceftriaxone for very severe cases. A macrolide, preferably erythromycin, should be employed when the etiologic agent is suspected to be Chlamydia trachomatis, C. pneumoniae, Mycoplasma pneumoniae, or Bordetella pertussis. The diagnosis of pneumonia and the need for hospitalization can be based on clinical assessment. The main antibiotics to be used are amoxicillin, penicillin, erythromycin, ampicillin, oxacillin, chloramphenicol, ceftriaxone, and aminoglycosides, depending on the age of the patient and the severity of the disease.